Atlas Trials

Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder

Clinical trial NCT00644969 · COMPLETED

Trial details

NCT number
NCT00644969
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Smoking Cessation
Start date
2008-05-01
Primary completion
2010-04-01
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.